Medical Journals

Nmda Receptor Blockers Prevents the Facilitatory Effects of Post-training Intra-dorsal Hippocampal Nmda and Physostigmine on Memory Retention of Passive Avoidance Learning in Rats.

Authors:
  • Jafari-Sabet Majid

From: Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, P.O. Box 13145-784, Tehran, Iran. jafarisa@sina.tums.ac.ir

Behavioural brain research

  • Publish Date: Apr 2006
  • ISSN: 0166-4328
  • Volume: 169
  • Issue: 1
  • Pages: 120-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Jafari-Sabet Majid, et al. Nmda Receptor Blockers Prevents the Facilitatory Effects of Post-training Intra-dorsal Hippocampal Nmda and Physostigmine on Memory Retention of Passive Avoidance Learning in Rats.. Behav. Brain Res. Apr 2006;169:120-7

Abstract

In the present study, the effects of post-training intra-dorsal hippocampal (intra-CA1) injection of an N-methyl-D-aspartate (NMDA) receptor agonist and competitive or noncompetitive antagonists, on memory retention of passive avoidance learning was measured in the presence and absence of physostigmine in rats. Intra-CA1 administration of lower doses of the NMDA receptor agonist NMDA (10(-5) and 10(-4) microg/rat) did not affect memory retention, although the higher doses of the drug (10(-3), 10(-2) and 10(-1) microg/rat) increased memory retention. The greatest response was obtained with 10(-1) microg/rat of the drug. The different doses of the competitive NMDA receptor antagonist DL-AP5 (1, 3.2 and 10 microg/rat) and noncompetitive NMDA receptor antagonist MK-801 (0.5, 1 and 2 microg/rat) decreased memory retention in rats dose dependently. Both competitive and noncompetitive NMDA receptor antagonists reduced the effect of NMDA (10(-2) microg/rat). In another series of experiments, intra-CA1 injection of physostigmine (2, 3 and 4 microg/rat) improved memory retention. Post-training co-administration of lower doses of NMDA (10(-5) and 10(-4) microg/rat) and physostigmine (1 microg/rat), doses which were ineffective when given alone, significantly improved the retention latency. The competitive and noncompetitive NMDA receptor antagonists, DL-AP5 and MK-801, decreased the effect of physostigmine (2 microg/rat). Atropine decreased memory retention by itself and potentiated the response to DL-AP5 and MK-801. In conclusion, it seems that both NMDA and cholinergic systems not only play a part in the modulation of memory in the dorsal hippocampus of rats but also have demonstrated a complex interaction as well.

Mesh Headings (Keywords): Analysis of Variance, Animals, Association Learning, Avoidance Learning, Cholinergic Fibers, Cholinesterase Inhibitors, Excitatory Amino Acid Antagonists, Hippocampus, Male, Memory, Microinjections, N-Methylaspartate, Physostigmine, Rats, Rats, Wistar, Receptors, N-Methyl-D-Aspartate


Check for Full Text / PubMed Unique Identifier (PMID): 16443290


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.